Companies
/Healthcare
Axogen Inc
$37.73
▲ $1.05 (+2.86%) today
Markets open · 1:55pm ET
AXGN at a Glance
Valuation
- Market cap
- $2.2B
Profitability
- Revenue (TTM)
- $251.2M
- Profit margin
- -13.4%
- EPS (TTM)
- $-0.67
Price
- 52-week range
- $17 – $53
- Street target
- $53.55
Earnings
- Next report
- Oct 28, 2026
Headquartered in Alachua, FL Fiscal year ends December NASDAQ: AXGN axogeninc.com
About Axogen
AxoGen, Inc. specializes in innovative technologies for the regeneration and repair of peripheral nerves. With a focus on improving quality of life, its product lineup includes the Avance Nerve Graft for bridging severed nerves, AxoGuard Nerve Connector for tensionless repair, and AxoGuard Nerve Protector to wrap and safeguard damaged nerves. Additionally, AxoGen offers the Axoguard Nerve Cap to protect nerve ends and the AxoTouch for assessing skin innervation. Serving hospitals and surgeons across the globe, AxoGen is a leader in its field, headquartered in Alachua, Florida.
Frequently Asked Questions
What does Axogen do?
AxoGen, Inc. specializes in innovative technologies for the regeneration and repair of peripheral nerves.
What is the AXGN stock price target?
The Wall Street consensus 12-month price target for AXGN is $53.55.